Y. Zeng et al. / Carbohydrate Research 337 (2002) 2383–2391
2389
mL), Ac2O (1 mL, 10 mmol) was added dropwise, and
4-Methoxyphenyl 2,3,4,6-tetra-O-benzoyl-i-
pyranosyl-(16)-2,4-di-O-acetyl-3-O-allyl-i-
pyranosyl-(13)-2-O-acetyl-4,6-O-benzylidene-i-
D
-gluco-
the mixture was stirred overnight at rt. TLC (1.5:1
petroleum ether–EtOAc) indicated that the reaction
was complete. The mixture was diluted with CH2Cl2,
washed with 1N HCl, water, and then with satd aq
NaHCO3. The organic layers were combined, dried,
and concentrated. Purification by column chromatog-
raphy (2:1 petroleum ether–EtOAc) gave 16 (220 mg,
74% for two steps) as a syrup: [h]D +43.1° (c 1.0,
CHCl3); 1H NMR (400 MHz, CDCl3): l 8.08–7.32
(m, 60 H, 12 BzH), 6.81 (dd, 4 H, ꢀC6H4ꢀ), 5.85 (dd,
1 H, J 9.6 Hz), 5.84 (dd, 1 H, J 9.6 Hz), 5.76 (dd, 1
H, J 9.6 Hz), 5.66–5.62 (m, 3 H), 5.49 (dd, 1 H, J 9.2
Hz), 5.47 (dd, 1 H, J 9.6 Hz), 5.37 (dd, 1 H, J 9.6
Hz), 4.96 (d, 1 H, J 8.0 Hz, bH-1), 4.91 (dd, 1 H, J
9.6 Hz), 4.89 (d, 1 H, J 8.0 Hz, bH-1), 4.82 (dd, 1 H,
J 8.0 Hz, bH-1), 4.63–4.55 (m, 6 H), 4.52–4.47 (m, 4
H), 4.43 (d, 1 H, J 8.0 Hz, bH-1), 4.16–4.09 (m, 2 H),
3.97–3.94 (m, 1 H), 3.88–3.80 (m, 3 H), 3.76 (s, 3 H,
CH3O), 3.67–3.62 (m, 2 H), 3.57–3.51 (m, 2 H),
3.49–3.42 (m, 1 H), 2.04, 1.86, 1.86, 1.66 (4 CH3CO);
13C NMR (100 MHz, CDCl3): l 169.53, 169.10,
168.76, 168.20 (4 CH3CO), 166.02, 165.97, 165.93,
165.76, 165.64, 165.57, 165.17, 165.15, 165.09, 165.04,
164.98, 164.75 (12 C6H5CO), 155.84, 151.27, 133.61,
133.44, 133.40, 133.34, 133.31, 133.21, 133.18, 133.15,
133.08, 132.85, 118.07, 116.41, 101.14, 100.35, 100.35,
99.83, 99.47 (5 C-1), 73.85. 73.54, 73.01, 72.77, 72.77,
72.57, 72.35, 72.38, 72.15, 71.86, 71.86, 71.76, 71.45,
69.44, 69.40, 69.33, 68.85, 68.26, 67.67, 62.67, 55.53,
20.96, 20.82, 20.75, 20.40. Anal. Calcd for
D
-gluco-
D-
glucopyranoside (18).—Compound 18 was prepared by
coupling of 10 (800 mg, 0.78 mmol) with 12 (210 mg,
0.78 mmol) under the same conditions as described for
the synthesis of 3 by coupling of 1 with 2. Concentra-
tion of the reaction mixture, followed by purification
on a silica gel column with 3:1 petroleum ether–
EtOAc as the eluent, gave the product. Acetylation in
pyridine (10 mL) with Ac2O (1 mL), and concentra-
tion, then purification of the residue by flash chro-
matography (2:1 petroleum ether–EtOAc) gave 18
(950 mg, 67% for two steps) as a syrup: [h]D +17.0°
1
(c 0.5, CHCl3); H NMR (400 MHz, CDCl3): l 7.90–
7.32 (m, 25 H, 5 PhH), 6.95–6.82 (dd, 4 H, ꢀC6H4ꢀ),
5.88 (dd, 1 H, J4¦,5¦=J3¦,4¦=9.6 Hz, H-4¦), 5.70–5.68
(m, 2 H, ꢀCHꢁ, H-3¦), 5.66 (dd, 1 H, J2¦,3¦=J1¦,2¦
9.6 Hz, H-2¦), 5.46 (s, 1 H, pHCH), 5.35 (dd, 1 H,
2,3=J1,2=9.6 Hz, H-2), 5.16–5.07 (m, 2 H, ꢁCH2),
=
J
5.01 (d, 1 H, J1¦,2¦ 8.0 Hz, H-1¦), 4.87 (dd, 1 H, J3%,4%
8.0 Hz, J4%,5% 9.6 Hz, H-4%), 4.80 (dd, 1 H, J1,2 8.0 Hz,
J2,3 9.6 Hz, H-2%), 4.78 (d, 1 H, J
8.0 Hz, H-1), 4.62
1,2
(m, 1 H, H-6¦a), 4.54 (m, 1 H, H-6¦b), 4.45 (d, 1 H,
J1%,2% 8.0 Hz, H-1%), 4.24–4.16 (m, 2 H), 3.97–3.82 (m,
4 H), 3.81 (s, 3 H, CH3O), 3.73–3.56 (m, 3 H), 3.49–
3.44 (m, 3 H), 1.96, 1.80, 1.75 (3 s, 3 CH3CO). Anal.
Calcd for C69H68O24: C, 64.69; H, 5.31. Found: C,
64.71; H, 5.28.
4-Methoxyphenyl 2,3,4,6-tetra-O-benzoyl-i-
pyranosyl-(16)-2,4-di-O-acetyl-3-O-allyl-i-
pyranosyl-(13)-2,4,6-tri-O-acetyl-i-
D
-gluco-
D
-gluco-
C129H114O43: C, 65.87; H, 4.85. Found: C, 65.88; H,
D
-glucopyran-
4.82. Anal. Calcd for C129H114O43: C, 65.87; H, 4.85.
Found: C, 65.79; H, 4.87.
oside (20).—Compound 19 (220 mg, 84%) was pre-
pared by debenzylidenation of 18 (280 mg, 0.22 mmol)
under the same conditions as described for the prepa-
ration of 14 with AcCl in MeOH. For the convenience
of identification, 19 (50 mg) was acetylated with Ac2O
in pyridine to give 20 (45 mg, 92%) as a syrup: [h]D
4-Methoxyphenyl i-
glucopyranosyl - (16)] - i -
[i- -glucopyranosyl-(16)]-i-
D
-glucopyranosyl-(13)-[i-
- glucopyranosyl - (13)-
-glucopyranoside (17).
D-
D
D
D
—Compound 16 (200 mg, 0.085 mmol) was added to
an NH3-satd MeOH solution (40 mL). After a week at
rt, the reaction mixture was concentrated, and the
residue was purified by chromatography on Sephadex
LH-20 (column 2.0×30 cm, flow 5 mL/min, about
300 mL MeOH) to afford the product 17 (75 mg,
95%) as a white amorphous powder: [h]D +24.2° (c
1
+27.6° (c 1.0, CHCl3); H NMR (400 MHz, CDCl3):
l 8.06–7.29 (m, 20 H, 4 BzH), 6.92–6.83 (dd, 4 H,
ꢀC6H4ꢀ), 5.92 (dd, 1 H, J3¦,4¦=J4¦,5¦=9.6 Hz, H-4¦),
5.80 (m, 1 H, ꢀCHꢁ), 5.70 (t, 1 H, J3¦,4¦=J2¦,3¦=9.8
Hz, H-3¦), 5.50 (dd, 1 H, J1¦,2¦ 8.0 Hz, J2¦,3¦ 9.6 Hz,
H-2¦), 5.27–5.16 (m, 2 H, CH2ꢁ), 5.08 (d, 1 H, J1¦,2¦
8.0 Hz, H-1¦), 5.01 (dd, 1 H, J3,4=J4,5=9.8 Hz, H-4),
4.88 (dd, 1 H, J1,2=J2,3=9.8 Hz, H-2), 4.83 (d, 1 H,
J1,2 8.0 Hz, H-1), 4.81 (m, 2 H, H-4%, H-2%), 4.72 (dd, 1
1
5.0, HOCH3); H NMR (400 MHz, D2O): l 6.80 (dd,
4 H, ꢀC6H4ꢀ), 4.93 (d, 1 H, J 7.6 Hz, H-1),), 4.74 (d,
1 H, J 7.6 Hz, H-1), 4.63 (d, 1 H, J 8.0 Hz, H-1), 4.41
(d, 1 H, J 7.6 Hz, H-1), 4.35 (d, 1 H, J 7.6 Hz, H-1),
4.09 (m, 2 H), 3.82–3.22 (m, 31 H); 13C NMR (100
MHz, D2O): l 157.33, 153.21, 120.92, 117.63, 105.23,
105.23, 105.04, 105.04, 103.36 (5 C-1), 87.45, 86.92 (2
C-3), 78.48, 78.32, 78.22, 78.17, 77.45, 77.02, 75.98,
75.85, 75.66, 75.50, 74.85, 72.16, 71.23, 70.76, 70.69,
70.55, 63.31, 63.31, 63.31, 58.42. Anal. Calcd for
C37H58O27: C, 47.53; H, 6.21. Found: C, 47.68; H,
6.12.
H, J6% ,6% 10.4 Hz, J5%,6% 3.0 Hz, H-6%a), 4.64 (dd, 1 H,
a
b
J6% ,6% 10.4 Hz, J5%,6% 3.2 Hz, H-6%b), 4.47 (d, 1 H, J1,2
8.0 Hz, H-1%), 4.14–3.88 (m, 5 H), 3.82 (s, 3 H,
CH3O), 3.78–3.42 (m, 6 H), 2.09, 2.07, 2.04, 1.92, 1.81
(5 s, 5 CH3CO). Anal. Calcd for C66H68O26: C, 62.07;
H, 5.33. Found: C, 62.32; H, 5.37.
a
b
4-Methoxyphenyl 2,3,4,6-tetra-O-benzoyl-i-
pyranosyl-(16)-2,4-di-O-acetyl-3-O-allyl-i-
D
-gluco-
D
-gluco-